首页> 美国卫生研究院文献>other >REV1 and DNA polymerase zeta in DNA interstrand crosslink repair
【2h】

REV1 and DNA polymerase zeta in DNA interstrand crosslink repair

机译:Rev1和DNA聚合酶Zeta在DNA Interstrand Crosslink修复中

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

DNA interstrand crosslinks (ICLs) are covalent linkages between two strands of DNA and their presence interfere with essential metabolic processes such as transcription and replication. These lesions are extremely toxic and their repair is essential for genome stability and cell survival. In this review, we will discuss how the removal of ICLs requires interplay between multiple genome maintenance pathways and can occur in the absence of replication (replication-independent ICL repair) or during S phase (replication-coupled ICL repair), the latter being the predominant pathway used in mammalian cells. It is now well recognized that translesion DNA synthesis (TLS), especially through the activities of REV1 and DNA polymerase zeta (Polζ), is necessary for both ICL repair pathways operating throughout the cell cycle. Recent studies suggest that the convergence of two replication forks upon an ICL initiates a cascade of events including unhooking of the lesion through the actions of structure-specific endonucleases thereby creating a DNA double stranded break (DSB). TLS across the unhooked lesion is necessary for restoring the sister chromatid prior to homologous recombination (HR) repair. Biochemical and genetic studies implicate REV1 and Polζ as being essential for performing lesion bypass across the unhooked crosslink and this step appears to be important for subsequent events to repair the intermediate DSB. The potential role of Fanconi anemia pathway in the regulation of REV1 and Polζ-dependent TLS and the involvement of additional polymerases, including DNA polymerases kappa, nu, and theta, in the repair of ICLs is also discussed in this review.
机译:DNA链间交联(ICL)是两条DNA链之间的共价键,它们的存在会干扰基本的代谢过程,例如转录和复制。这些病变具有剧毒,其修复对于基因组稳定性和细胞存活至关重要。在这篇综述中,我们将讨论如何去除ICL要求多个基因组维持途径之间的相互作用,以及如何在不存在复制(独立于复制的ICL修复)或在S期(复制耦合ICL修复)期间发生,后者是在哺乳动物细胞中使用的主要途径。现在众所周知,跨细胞DNA合成(TLS),特别是通过REV1和DNA聚合酶zeta(Polζ)的活性,对于整个细胞周期中运行的两种ICL修复途径都是必需的。最近的研究表明,在ICL上两个复制叉的融合会引发一系列事件,包括通过结构特异性核酸内切酶的作用使病变脱钩,从而形成DNA双链断裂(DSB)。为了在同源重组(HR)修复之前恢复姐妹染色单体,必须跨越未钩住的病灶进行TLS。生化和基因研究表明REV1和Polζ是跨未钩连的交联进行病灶旁路必不可少的步骤,这一步骤对于后续修复中间DSB的事件似乎很重要。本文还讨论了Fanconi贫血途径在REV1和Polζ依赖性TLS调控中的潜在作用,以及其他聚合酶(包括DNA聚合酶kappa,nu和theta)在ICL修复中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号